Activation or frustration of anti-tumor responses by T-cell-based immune modulation

Seminars in Immunology

Volumn 9, Issue 5, 1997, Pages 323-327

  Toes, René E M ^a   Schoenberger, Stephen P ^a   Van Der Voort, Ellen I H ^a   Kast, W Martin ^b   Hoeben, Rob C ^c   Melief, C J M ^a   Offringa, Rienk ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^c NONE

Author keywords

Cytotoxic T lymphocyte; Dendritic cell; Peptide immunization; Recombinant adenovirus vaccine; String of bead vaccines

Indexed keywords

TUMOR VACCINE;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNIZATION; CELLULAR IMMUNITY; IMMUNOMODULATION; SHORT SURVEY; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0031251984     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1997.0088     Document Type: Article

References (27)

1. 1. Melief CJM (1992) Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 58:143-175
2. 2. Melief CJM, Vasmel WLE, Offringa R, Sijts EJAM, Matthews EA, Peters PJ, Meloen RH, Van der Eb AJ, Kast WM (1989) Immunosurveillance of virus-induced tumors. Cold Spring Harbour Symp Quant Biol 54:597-603
3. 3. Boon T, Cerottini J-C, van den Eynde B, van der Bruggen P, van Pel A (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337-365
4. 4. Rammensee H-G, Falk K, Rötschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213-244
5. 5. Neefjes JJ, Momburg F (1993) Cell biology of antigen presentation. Curr Opin Immunol 5:27-34
6. 6. Feltkamp MCW, Vreugdenhil GR, Vierboom MPM, Ras E, Van der Burg SH, Ter Schegget J, Melief CJM, Kast WM (1995) CTL raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur J Immunol 25:2638-2641
7. 7. Schoenberger SP, Sercarz EE (1996) Harnessing self-reactivity in cancer immunotherapy. Semin Immunol 8:303-309
8. 8. Feltkamp MCW, Smits HL, Vierboom MPM, Minnaar RP, De Jongh BM, Drijfhout JW, Ter Schegget J, Melief CJM, Kast WM (1993) Vaccination with a cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human Papillomavirus type 16-transformed cells. Eur J Immunol 23:2242-2249
9. + T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res 54:4155-4161
10. 10. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L (1996) CTL induction y a tumor-associated antigen octa-peptide derived from a murine lung carcinoma. Nature 369:67-71
11. 11. Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, Van der Eb AJ, Melief CJM (1989) Eradication of adenovirus El-induced tumors by Ela-specific cytotoxic T lymphocytes. Cell 59:603-615
12. 12. Toes REM, Offringa R, Blom RJJ, Melief CJM, Kast WM (1996) Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc Natl Acad Sci USA 93:7855-7860
13. 13. Toes REM, Blom RJJ, Offringa R, Kast WM, Melief CJM (1996) Functional deletion of tumor-specific cytotoxic T lymphocytes induced by peptide immunization can lead to the inability to reject tumors. J Immunol 156:3911-3918
14. 14. Aichele P, Kyburz D, Ohashi PS, Odermatt B, Zinkernagel RM, Hengartner H, Pircher H (1994) Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci USA 91:444-448
15. 15. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJM, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pusled with synthetic tumor peptides elicit protective and therapeutic antitumour immunity. Nature Med 1:1297-1302
16. 16. Mayordomo JI, Loftus DJ, Sakamoto H, De Cesare CM, Appasamy PM, Lotze MT, Storkus WJ, Appella E, DeLeo AB (1996) Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J Exp Med 183:1357-1365
17. 17. Mayordomo JI, Loftus DJ, Sakamoto H, De Cesar CM, Appasamy PM, Lotze MT, Storkus WJ, Appella E, de Leo AB (1996) Therapy of murine tumors with dendritic cells pulsed with p53 wild type and mutant sequence peptides. J Exp Med 183:1357-1365
18. 18. Hoover HC, Surdyke MG, Dangel RB, Peters LC, Hanna MG (1985) Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer 55:1236-1243
19. 19. Berd D, Maguire HC, McCue P, Mastrangelo MJ (1990) Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients. J Clin Oncol 8:1858-1867
20. 20. Earth A, Hoon DSB, Foshag LJ, Nizze A, Famatiga E, Okun E, Morton DL (1994) Polyvalent melanoma cell vaccine induces delayed-type hyper sensitivity and in vitro cellular immune response. Cancer Res 54:3342-3345
21. 21. Toes REM, Blom RJJ, van der Voort E, Offringa R, Melief CJM, Kast WM (1996) Protective anti-tumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res 56:3782-3787
22. 22. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-965
23. 23. Whitton JL, Sheng N, Oldstone MBA, McKee TA (1995) A 'string-of-beads' vaccine, comprising linked minigenes confers protection from lethal-dose virus challenge. J Virol 67:348-352
24. 24. Thomson SA, Elliott SL, Sherritt MA, Sproat KW, Coupar BEH, Scalzo AA, Forbes CA, Ladhams AM, Mo XY, Tripp RA, Doherty PC, Moss DJ, Suhrbier A (1996) Recombinant polyepitope vaccines for the delivery of multiple cytotoxic T cell epitopes. J Immunol 157:822-826
25. 25. Top FH, Buescher EL, Bancroft WH, Russell PK (1971) Immunization with live types 7 and 4 adenovirus vaccines. II Antibody response and protective effects against acute respiratory disease due to adenovirus type 7. J Infect Dis 124:155-160
26. 26. Chen PW, Wang M, Bronte V, Zhai Y, Rosenberg SA, Restifo NP (1996) Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol 156:224-231
27. 27. Zur Hausen H (1991) Human papillomavirus in the pathogenesis of anogenital cancer. Virology 184:9-13